Genotyping and screening of reassortant live-attenuated influenza B vaccine strain

Journal of Virological Methods

Volumn 165, Issue 2, 2010, Pages 133-138

  Lee, Eun Young ^a   Lee, Kwang Hee ^a   Jung, Eun Ju ^a   Jang, Yo Han ^a   Seo, Sang Uk ^a   Kim, Hyun Ah ^b   Seong, Baik Lin ^a  

^a Yonsei University   (South Korea)

^b CJ Corporation   (South Korea)

Author keywords

Genotyping; Influenza B virus; Live vaccine; Multiplex RT PCR; Reassortants

Indexed keywords

INFLUENZA VACCINE; LIVE VACCINE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG SCREENING; EMBRYO; GENE AMPLIFICATION; GENE IDENTIFICATION; GENETIC REASSORTMENT; GENOTYPE; INFLUENZA VIRUS B; MOLECULAR CLONING; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEASONAL INFLUENZA; VIRUS CULTURE; VIRUS GENE; VIRUS STRAIN; WILD TYPE;

COLD TEMPERATURE; DNA PRIMERS; DNA, COMPLEMENTARY; HUMANS; INFLUENZA B VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; REASSORTANT VIRUSES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VACCINES, ATTENUATED; VIRAL PROTEINS;

INFLUENZA B VIRUS; ORTHOMYXOVIRIDAE;

EID: 77951025130     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2009.10.022     Document Type: Article

References (36)

1. Bardiya N., Bae J.H. Influenza vaccines: recent advances in production technologies. Appl. Microbiol. Biotechnol. 2005, 67:299-305.
2. Beigel J., Bray M. Current and future antiviral therapy of severe seasonal and avian influenza. Antiviral Res. 2008, 78:91-102.
3. Beigel J.H. Influenza. Crit. Care Med. 2008, 36:2660-2666.
4. Belshe R., Lee M.S., Walker R.E., Stoddard J., Mendelman P.M. Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine. Expert Rev. Vaccines 2004, 3:643-654.
5. Belshe R.B. Current status of live attenuated influenza virus vaccine in the US. Virus Res. 2004, 103:177-185.
6. Carrat F., Flahault A. Influenza vaccine: the challenge of antigenic drift. Vaccine 2007, 25:6852-6862.
7. Cha T.A., Zhao J., Lane E., Murray M.A., Stec D.S. Determination of the genome composition of influenza virus reassortants using multiplex reverse transcription-polymerase chain reaction followed by fluorescent single-strand conformation polymorphism analysis. Anal. Biochem. 1997, 252:24-32.
8. Chi X.S., Li F., Tam J.S., Rappaport R., Cheng S.M. Semiquantitative one-step RT-PCR for simultaneous identification of human influenza and respiratory syncytial viruses. J. Virol. Methods 2007, 139:90-92.
9. Cooper L.A., Subbarao K. A simple restriction fragment length polymorphism-based strategy that can distinguish the internal genes of human H1N1, H3N2, and H5N1 influenza A viruses. J. Clin. Microbiol. 2000, 38:2579-2583.
10. Cox R.J., Brokstad K.A., Ogra P. Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines. Scand. J. Immunol. 2004, 59:1-15.
11. De Clercq E. Antiviral drugs in current clinical use. J. Clin. Virol. 2004, 30:115-133.
12. Ellis J.S., Zambon M.C. Combined PCR-heteroduplex mobility assay for detection and differentiation of influenza A viruses from different animal species. J. Clin. Microbiol. 2001, 39:4097-4102.
13. Ha S.H., Kim H.A., Kim Y.H., Kim J.S., Lee K.H., Park S.Y., Park W.J., Seong B.L. A multiplex RT-PCR method for screening of reassortant live influenza vaccine virus strains. J. Virol. Methods 2006, 134:154-163.
14. Hampson A.W., Mackenzie J.S. The influenza viruses. Med. J. Aust. 2006, 185:S39-S43.
15. Hoffmann E., Krauss S., Perez D., Webby R., Webster R.G. Eight-plasmid system for rapid generation of influenza virus vaccines. Vaccine 2002, 20:3165-3170.
16. Hoffmann E., Neumann G., Kawaoka Y., Hobom G., Webster R.G. A DNA transfection system for generation of influenza A virus from eight plasmids. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:6108-6113.
17. Intharathep P., Laohpongspaisan C., Rungrotmongkol T., Loisruangsin A., Malaisree M., Decha P., Aruksakunwong O., Chuenpennit K., Kaiyawet N., Sompornpisut P., Pianwanit S., Hannongbua S. How amantadine and rimantadine inhibit proton transport in the M2 protein channel. J. Mol. Graph. Model. 2008, 27:342-348.
18. Klimov A.I., Cox N.J. PCR restriction analysis of genome composition and stability of cold-adapted reassortant live influenza vaccines. J. Virol. Methods 1995, 52:41-49.
19. Kwok S., Kellogg D.E., McKinney N., Spasic D., Goda L., Levenson C., Sninsky J.J. Effects of primer-template mismatches on the polymerase chain reaction: human immunodeficiency virus type 1 model studies. Nucleic Acids Res. 1990, 18:999-1005.
20. Maassab H.F., Bryant M.L. The development of live attenuated cold-adapted influenza virus vaccine for humans. Rev. Med. Virol. 1999, 9:237-244.
21. Moscona A. Medical management of influenza infection. Annu. Rev. Med. 2008, 59:397-413.
22. Nerome K., Sakamoto S., Yano N., Yamamoto T., Kobayashi S., Webster R.G., Oya A. Antigenic characteristics and genome composition of a naturally occurring recombinant influenza virus isolated from a pig in Japan. J. Gen. Virol. 1983, 64(Pt 12):2611-2620.
23. Neumann G., Watanabe T., Ito H., Watanabe S., Goto H., Gao P., Hughes M., Perez D.R., Donis R., Hoffmann E., Hobom G., Kawaoka Y. Generation of influenza A viruses entirely from cloned cDNAs. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:9345-9350.
24. Offringa D.P., Tyson-Medlock V., Ye Z., Levandowski R.A. A comprehensive systematic approach to identification of influenza A virus genotype using RT-PCR and RFLP. J. Virol. Methods 2000, 88:15-24.
25. Ohmit S.E., Victor J.C., Teich E.R., Truscon R.K., Rotthoff J.R., Newton D.W., Campbell S.A., Boulton M.L., Monto A.S. Prevention of symptomatic seasonal influenza in 2005-2006 by inactivated and live attenuated vaccines. J. Infect. Dis. 2008, 198:312-317.
26. Palese P., Schulman J.L. Differences in RNA patterns of influenza A viruses. J. Virol. 1976, 17:876-884.
27. Poddar S.K. Influenza virus types and subtypes detection by single step single tube multiplex reverse transcription-polymerase chain reaction (RT-PCR) and agarose gel electrophoresis. J. Virol. Methods 2002, 99:63-70.
28. Sakamoto S., Kino Y., Oka T., Herlocher M.L., Maassab F. Gene analysis of reassortant influenza virus by RT-PCR followed by restriction enzyme digestion. J. Virol. Methods 1996, 56:161-171.
29. Seo S.U., Byun Y.H., Lee E.Y., Jung E.J., Jang Y.H., Kim H.A., Ha S.H., Lee K.H., Seong B.L. Development and characterization of a live attenuated influenza B virus vaccine candidate. Vaccine 2008, 26:874-8781.
30. Seo S.U., Lee K.H., Byun Y.H., Kweon M.N., Seong B.L. Immediate and broad-spectrum protection against heterologous and heterotypic lethal challenge in mice by live influenza vaccine. Vaccine 2007, 25:8067-8076.
31. Shi H., Liu X.F., Zhang X., Chen S., Sun L., Lu J. Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses. Vaccine 2007, 25:7379-7384.
32. Song M.S., Oh T.K., Pascua P.N., Moon H.J., Lee J.H., Baek Y.H., Woo K.J., Yoon Y., Sung M.H., Poo H., Kim C.J., Choi Y.K. Investigation of the biological indicator for vaccine efficacy against highly pathogenic avian influenza (HPAI) H5N1 virus challenge in mice and ferrets. Vaccine 2009, 27:3145-3152.
33. Stockton J., Ellis J.S., Saville M., Clewley J.P., Zambon M.C. Multiplex PCR for typing and subtyping influenza and respiratory syncytial viruses. J. Clin. Microbiol. 1998, 36:2990-2995.
34. Suguitan A.L., McAuliffe J., Mills K.L., Jin H., Duke G., Lu B., Luke C.J., Murphy B., Swayne D.E., Kemble G., Subbarao K. Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets. PLoS Med. 2006, 3:1541-1555.
35. Wareing M.D., Tannock G.A. Live attenuated vaccines against influenza; an historical review. Vaccine 2001, 19:3320-3330.
36. Wright P.F., Newman G., Kawaoka Y. Orthomyxoviruses. Fields Virology 2007, 1691-1740. Lippincott Williams and Wilkins, a Wolters Kluwer Business, Philadelphia. D.M. Knipe, P.M. Howley, D.E. Griffin (Eds.).